Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Association of Anti-Modified Citrullinated Vimentin with Subclinical Atherosclerosis in Early Rheumatoid Arthritis Compared with Anti-Cyclic Citrullinated Peptide

Amal M. El-Barbary, Elham M. Kassem, Mervat A.S. El-Sergany, Salwa A-M. Essa and Mohamed A. Eltomey
The Journal of Rheumatology March 2011, jrheum.101143; DOI: https://doi.org/10.3899/jrheum.101143
Amal M. El-Barbary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elham M. Kassem
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mervat A.S. El-Sergany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salwa A-M. Essa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed A. Eltomey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
Next
Loading

Article Information

jrheum.101143
DOI 
https://doi.org/10.3899/jrheum.101143
PubMed 
21362765

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online March 1, 2011.

Article Versions

  • You are currently viewing a Latest version of this article (March 1, 2011 - 04:00).
  • View the most recent version of this article
Copyright & Usage 
© 2011 The Journal of Rheumatology

Author Information

  1. Amal M. El-Barbary,
  2. Elham M. Kassem,
  3. Mervat A.S. El-Sergany,
  4. Salwa A-M. Essa and
  5. Mohamed A. Eltomey
  1. From the Department of Rheumatology and Rehabilitation, Department of Clinical Pathology, and Department of Radiology, Tanta University Faculty of Medicine, Tanta, Gharbeia, Egypt.
    A.M. El-Barbary, MD, Lecturer; E.M. Kassem, MD, Assistant Professor; M.A.S. El-Sergany, MD, Assistant Professor, Department of Rheumatology and Rehabilitation; S.A-M. Essa, MD, Assistant Professor, Department of Clinical Pathology; M.A. Eltomey, MD, Lecturer, Department of Radiology, Faculty of Medicine, Tanta University.
    Address correspondence to Dr. A.M. El-Barbary, Department of Rheumatology and Rehabilitation, Tanta University Faculty of Medicine, Elgesh Street, Tanta, Gharbeia, Egypt. E-mail:ml_barbary{at}yahoo.com
    Accepted for publication January 11, 2011.

Article usage

Article usage: February 2011 to January 2026

AbstractFullPdf
Feb 2011201
Mar 2011382039
Apr 2011100814
May 20118381265
Jun 20112341416
Jul 20118749
Aug 2011102126
Sep 20118398
Oct 20118214
Nov 20119379
Dec 20118446
Jan 20128573
Feb 20127133
Mar 20125433
Apr 20126420
May 20125522
Jun 20125645
Jul 20125112
Aug 20124588
Sep 20123755
Oct 20126711
Nov 20124213
Dec 20123601
Jan 20139424
Feb 20134512
Mar 20133213
Apr 20133432
May 20132902
Jun 20132413
Jul 20131912
Aug 20132511
Sep 2013821
Oct 20132212
Nov 20131721
Dec 20132402
Jan 2014733
Feb 20141123
Mar 20141935
Apr 20141623
May 20142133
Jun 20141802
Jul 2014714
Aug 20141211
Sep 20141455
Oct 20142214
Nov 20141341
Dec 2014901
Jan 20151235
Feb 20151723
Mar 20152803
Apr 20151410
May 20151411
Jun 20151701
Jul 20152300
Aug 2015922
Sep 20151122
Oct 20151600
Nov 2015521
Dec 20154100
Jan 20162000
Feb 2016722
Mar 2016801
Apr 20161024
May 20161500
Jun 20161701
Jul 20162113
Aug 20161611
Sep 20161800
Oct 20162300
Nov 20162802
Dec 20164521
Jan 20172811
Feb 20173112
Mar 20171700
Apr 20173431
May 20174221
Jun 20173511
Jul 20173200
Aug 20174563
Sep 20173555
Oct 20174633
Nov 20174111
Dec 20173601
Jan 20184801
Feb 20183100
Mar 20184322
Apr 20183200
May 20184211
Jun 20182301
Jul 20183400
Aug 20183110
Sep 20182100
Oct 20183011
Nov 20183000
Dec 20182200
Jan 20192500
Feb 20191602
Mar 2019910
Apr 20191400
May 20192635
Jun 20192510
Jul 20191433
Aug 20192000
Sep 2019711
Oct 20191510
Nov 20191611
Dec 20191800
Jan 2020732
Feb 2020362
Mar 2020352
Apr 20208116
May 20204188
Jun 20207153
Jul 20207337
Aug 20205148
Sep 202010225
Oct 20208107
Nov 202012179
Dec 202013132
Jan 2021575
Feb 202114175
Mar 202110174
Apr 202114143
May 202151180
Jun 202117135
Jul 20211361
Aug 2021597
Sep 20214104
Oct 20217143
Nov 20214196
Dec 2021886
Jan 20228117
Feb 2022573
Mar 20222073
Apr 20222933
May 2022121417
Jun 202210125
Jul 20226144
Aug 20223136
Sep 2022111610
Oct 2022880
Nov 2022574
Dec 2022274
Jan 20238496
Feb 2023682
Mar 20235115
Apr 2023662
May 202351118
Jun 2023684
Jul 202351624
Aug 2023755
Sep 202351311
Oct 202322946
Nov 2023242048
Dec 202343012
Jan 202493712
Feb 202410417
Mar 20248225
Apr 20241213418
May 202410836
Jun 2024101514
Jul 2024101617
Aug 202442411
Sep 2024143215
Oct 202410910
Nov 2024497
Dec 20246811
Jan 20255116
Feb 2025212312
Mar 2025125811
Apr 202594910
May 2025153615
Jun 2025272726
Jul 2025121719
Aug 202515813
Sep 202538207
Oct 2025392517
Nov 2025401926
Dec 2025383127
Jan 2026713523

Statistics from Altmetric.com

Next
Back to top

In this issue

The Journal of Rheumatology: 53 (3)
The Journal of Rheumatology
Vol. 53, Issue 3
1 Mar 2026
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Association of Anti-Modified Citrullinated Vimentin with Subclinical Atherosclerosis in Early Rheumatoid Arthritis Compared with Anti-Cyclic Citrullinated Peptide
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Association of Anti-Modified Citrullinated Vimentin with Subclinical Atherosclerosis in Early Rheumatoid Arthritis Compared with Anti-Cyclic Citrullinated Peptide
Amal M. El-Barbary, Elham M. Kassem, Mervat A.S. El-Sergany, Salwa A-M. Essa, Mohamed A. Eltomey
The Journal of Rheumatology Mar 2011, jrheum.101143; DOI: 10.3899/jrheum.101143

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Association of Anti-Modified Citrullinated Vimentin with Subclinical Atherosclerosis in Early Rheumatoid Arthritis Compared with Anti-Cyclic Citrullinated Peptide
Amal M. El-Barbary, Elham M. Kassem, Mervat A.S. El-Sergany, Salwa A-M. Essa, Mohamed A. Eltomey
The Journal of Rheumatology Mar 2011, jrheum.101143; DOI: 10.3899/jrheum.101143
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Evaluating the Applicability of the EULAR/ACR 2019, SLICC 2012, and ACR 1997 Classification Criteria for Systemic Lupus Erythematosus in Children: A Multicenter Study
  • Team-Based Outpatient Rheumatology Care: A Scoping Review of Terminology, Team Composition, and Impact on Advancing the Quintuple Aim
  • High Rates of Degenerative Changes in the Lower Spine in Calcium Pyrophosphate Deposition Disease Compared to Degenerative Disc Disease
Show more Article

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire